125 results
Page 4 of 7
S-3ASR
EX-4.4
vq59oc2n32whw50y
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-99.1
tqval
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am
8-K
EX-1.1
5uln090i
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-99.1
bxbxqvmnk7f oumw
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
EX-99.1
zz3bvltt 7k
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
uvi53gt 7zdamciim
5 Nov 20
Sutro Biopharma Reports Third Quarter 2020 Financial Results
7:05am
8-K
EX-99.1
yim6j4ttjc4 yo8iz
6 Aug 20
Sutro Biopharma Reports Second Quarter 2020 Financial Results
7:03am
8-K
EX-1.1
ki1kk
12 May 20
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
ps28274ng p05i8ooqfp
11 May 20
Sutro Biopharma Reports First Quarter 2020 Financial Results
4:27pm